Literature DB >> 3568471

Intermediate results of a straight stem prosthesis in primary total hip arthroplasty.

S B Goodman, J Schatzker.   

Abstract

In a retrospective study of 130 primary total hip arthroplasties with a self-locking straight stem femoral component (Muller) and low profile cup, the average follow-up evaluation was 3.1 years (range, 2.0-4.6 years). According to the clinical rating system modified from Swanson and Evarts, there were 115 (88.3%) excellent, six (4.7%) good, four (3.1%) fair, and five (3.9%) poor results. Radiolucent lines at least 1 mm in width were noted in 12.8% of acetabula, mostly in Zones 1 and III. One cup has been revised and one is awaiting revision. Radiolucent lines greater than or equal to 1 mm were noted around 26.5% of femoral components. These were asymptomatic, unless associated with the presence of infection, subsidence greater than 5 mm, or symptoms of acetabular loosening. True femoral subsidence was pain free and nonprogressive in seven patients (6%) if less than or equal to 5 mm. Femoral loosening was roentgenographically observed as component migration or subsidence greater than 5 mm. By these criteria, three femoral components (2.6%) were loose, although none have been revised.

Entities:  

Mesh:

Year:  1987        PMID: 3568471

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Aseptic loosening of straight- and curved-stem Müller femoral prostheses.

Authors:  M Krismer; M Klar; T Klestil; B Frischhut
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

2.  Comparison between straight- and curved-stem Müller femoral prostheses. 5- to 10-year results of 545 total hip replacements.

Authors:  J Wilson-MacDonald; E Morscher
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

3.  Subsidence of titanium straight stems in combination with highly viscous bone cement.

Authors:  Christian Hendrich; Ulf Sauer; Tobias Albrecht; Christof P Rader
Journal:  Int Orthop       Date:  2005-02-10       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.